About 4 results found for searched term "ABCG2-IN-1" (0.132 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M42162 | ABCG2-IN-1 | BCRP/ABCG2/MXR/ABCP |
| ABCG2-IN-1 is an orally active ABCG2 inhibitor with an IC50 of 0.13 μM. | ||
| M30477 | 6,8-Diprenylnaringenin | BCRP/ABCG2/MXR/ABCP |
| Lonchocarpol A; Senegalensin | ||
| 6,8-Diprenylnaringenin (Lonchocarpol A; Senegalensin), a hop prenylflavonoid, is a inhibitor of breast cancer resistance protein (BCRP/ABCG2). 6,8-Diprenylnaringenin inhibits ABCG2-mediated efflux of Mitoxantrone, and 3H-Methotrexate transport (IC50=0.41 μM) in HEK293 cells. 6,8-Diprenylnaringenin exhibits some estrogenicity, but its potency is less than 1% of that of 8-Prenylnaringenin. | ||
| M49909 | ML230 | BCRP/ABCG2/MXR/ABCP |
| CID44640177; SID 88095709 | ||
| ML230 is a selective inhibitor of the ATP-binding transporter subtype ABCG2, and its inhibitory effect on ABCG2 was 36 times that of ABCB1, with EC50 values of 0.13 μM and 4.65 μM, respectively. | ||
| M49911 | CCTA-1523 | BCRP/ABCG2/MXR/ABCP |
| CCTA-1523 is a potent, selective, reversible, and orally active ABCG2 inhibitor.CCTA-1523 exhibits cytotoxicity and anticancer activity. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
